Biogen Inc. buy Royal Bank of Canada
Start price
04.10.24
/
50%
€168.70
Target price
04.10.25
€245.41
Performance (%)
-29.96%
Price
29.09.25
€118.15
This prediction will end soon
Summary
This prediction is currently active. The prediction for Biogen Inc. disappoints with a performance of -29.96%. This prediction currently runs until 04.10.25. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Biogen Inc. | -0.881% | -0.881% |
| iShares Core DAX® | 0.696% | -0.706% |
| iShares Nasdaq 100 | 0.033% | 4.900% |
| iShares Nikkei 225® | -0.420% | 6.468% |
| iShares S&P 500 | 0.153% | 2.911% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its price target lowered by analysts at Royal Bank of Canada from $292.00 to $269.00. They now have an "outperform" rating on the stock.
Ratings data for BIIB provided by MarketBeat